Health and Fitness Health and Fitness
Wed, May 1, 2013
Tue, April 30, 2013
Mon, April 29, 2013
Sun, April 28, 2013
Fri, April 26, 2013
Thu, April 25, 2013
Wed, April 24, 2013
Tue, April 23, 2013
Mon, April 22, 2013
Sun, April 21, 2013
Fri, April 19, 2013
Thu, April 18, 2013
Wed, April 17, 2013
Tue, April 16, 2013
Mon, April 15, 2013
Fri, April 12, 2013
Thu, April 11, 2013
[ Thu, Apr 11th 2013 ] - Market Wire
15 PM EDT
Wed, April 10, 2013
Tue, April 9, 2013
[ Tue, Apr 09th 2013 ] - Market Wire
30 a.m. ET
Mon, April 8, 2013
Sat, April 6, 2013
Fri, April 5, 2013
Thu, April 4, 2013

Cempra, Inc. to Report First Quarter 2013 Financial and Operating Results, and Host Conference Call and Webcast on April 25, 20


//health-fitness.news-articles.net/content/2013/ .. -conference-call-and-webcast-on-april-25-20.html
Published in Health and Fitness on Thursday, April 18th 2013 at 13:16 GMT by Market Wire   Print publication without navigation


Cempra, Inc. to Report First Quarter 2013 Financial and Operating Results,... -- CHAPEL HILL, N.C., April 18, 2013 /PRNewswire/ --

CHAPEL HILL, N.C., April 18, 2013 /PRNewswire/ -- Cempra, Inc. (Nasdaq: [ CEMP ]) today announced that it will report first quarter 2013 financial results and provide a business update after the close of U.S. financial markets on April 25, 2013. Prabhavathi Fernandes, Ph.D., president and chief executive officer of Cempra, will host a conference call and webcast at 4:30 p.m. EDT, April 25, 2013.

The conference call may be accessed by dialing 877-377-7553 for domestic callers and 253-237-1151 for international callers. Please specify to the operator that you would like to join the "Cempra, Inc., First Quarter 2013 Financial Results Call, conference ID#: 33311244." The conference call will be webcast live under the investor relations section of Cempra's website at [ www.cempra.com ], and will be archived there for 30 days following the call. Please visit Cempra's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Cempra, Inc.
Founded in 2006, Cempra, Inc. is a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases. Cempra's two lead product candidates are in advanced clinical development; solithromycin in Phase 3 for CABP and TAKSTA™ (CEM-102) in Phase 2 for prosthetic joint infections. Both seek to address the need for new treatments targeting drug-resistant bacterial infections in the hospital and in the community. The company also intends to use its series of proprietary lead compounds from its novel macrolide library for uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. Additional information about Cempra can be found at [ www.cempra.com ].

Investor and Media Contacts:
Robert E. Flamm , Ph.D.
Russo Partners, LLC
(212) 845-4226 
[ Robert.flamm@russopartnersllc.com ]

Andreas Marathovouniotis
Russo Partners, LLC
(212) 845-4235
[ Andreas.marathis@russopartnersllc.com ]

SOURCE Cempra, Inc.



RELATED LINKS
[ http://www.cempra.com ]

Publication Contributing Sources